Screening for colorectal cancer: Recommendations and rationale

American Journal of Nursing

Volumn 102, Issue 9, 2002, Pages 107-X

  Berg, Alfred O ^a,b   Allan, Janet D ^c   Frame, Paul ^d,e   Homer, Charles J ^f   Johnson, Mark S ^g   Klein, Jonathan D ^h   Lieu, Tracy A ⁱ   Mulrow, Cynthia D ^j   Orleans, Tracy C ^k   Peipert, Jeffrey F ^l   Pender, Nola J ^m   Siu, Albert L ⁿ   Teutsch, Steven M ^o   Westhoff, Carolyn ^p   Woolf, Steven H ^q  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^d Tri County Family Medicine   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f National Initiative for Children's Healthcare Quality   (United States)

^g RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Mays Cancer Center at UT Health San Antonio   (United States)

^k ROBERT WOOD JOHNSON FOUNDATION   (United States)

^l WOMEN AND INFANTS HOSPITAL   (United States)

^m UNIVERSITY OF MICHIGAN   (United States)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^o MERCK RESEARCH LABORATORIES   (United States)

^p Och Spine at New York Presbyterian Hospitals   (United States)

^q VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PRACTICE GUIDELINE; REPRODUCIBILITY; REVIEW; UNITED STATES;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 0036730625     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:132-141.
2. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults. Systematic Evidence Review No. 7 (Prepared by the Research Triangle Institute-University of North Carolina Evidence-based Practice Center under Contract No. 290-97-0011). AHRQ Publication No. 02-S003. Rockville, MD: Agency for Health-care Research and Quality. June, 2002(Available only on AHRQ Web site at www.ahrq.gov/clinic/serfiles.htm).
3. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
4. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with special section on colorectal cancer. Cancer. 2000;88:2398-2424.
5. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987;93:1009-13
6. Winawer SJ and Shike, M. Prevention and control of colorectal cancer. In: Greenwald P.; Kramer BS; Weed DL, eds. Cancer Prevention and Control. New York: Marcel-Dekker, 1995. pp. 537-560.
7. Yamamoto M, Nakama H. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology. 2000;47(32):396-99.
8. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med. 1997;126(10):811-22.
9. Mandel J, Bond J, Church T, Snover D, Bradley M, Schuman L, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-71.
10. Hardcastle J, Chamberlain J, Robinson M, Moss S, Amar S, Balfour T, et al. Randomised controlled trial of fecal-occult-blood test. Lancet. 1996;348:1472-77.
11. Kronborg O, Fenger C, Olsen J, Jorgensen D, Sondergaard O. Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet. 1996;348:1467-71.
12. Atkin WE, Hart A, Edwards R, McIntyre P, Aubry R, Wardle J et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut. 1998;42:560-65
13. Lehman GA, Buchner DM, Lappas JC. Anatomical extent of fiberoptic sigmoidoscopy. Gastroenterology. 1983;84:803-8
14. Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med. 2000;342:393-97.
15. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterohgy. 1997;112:24-8
16. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-37.
17. Selby J, Friedman G, Quesenberry C, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-57.
18. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-75.
19. Winawer S. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311-18.
20. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329: 1977-81
21. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med. 1995;155:1741-48.
22. Nelson RL, Abcarian H, Prasad ML. Iatrogenic perforation of the colon and rectum. Dis Colon Rectum. 1982;25:305-8
23. Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK Consultant Radiologists 1992 to 1994. Clin Radiol. 1997;52:142-48.
24. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162-68.
25. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169-74.
26. Woolf SH. The best screening test for colorectal cancer - a personal choice. N Engl J Med. 2000;343:1641-3.
27. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin. 1997;47(3):154-60. Available at: www.cancer.org/ cancerinfo/documents/cancer_10/guidelines.html.
28. Goldstein MM, Messing EM. Prostate and bladder cancer screening. J Am Coll Surg. 1987;186(1):63-74. Available at: www.facs.org/dept/ jacs/articles/messing.html.
29. American College of Obstetricians and Gynecologists. Primary and preventive care: periodic assessments. ACOG Committee Opinion 246. Washington, DC: ACOG, 2000.
30. American Academy of Family Physicians. Summary of policy recommendations for periodic health examination. Revision 5.0, August 2001, Order No. 962, Reprint No. 510. Available at: www.aafp.org/exam/.
31. Solomon MJ, McLeod RS. Preventive health care, 2001 update. Colorectal cancer screening: recommendations statement. Canadian Task Force on the Periodic Health Examination. CMAJ. 2001;15(10): 647-60.